头颈癌风险预测模型的开发与外部验证
研究利用IARC-ARCAGE欧洲病例对照研究开发了基于行为与人口学预测因子的头颈癌临床风险预测模型,并在英国生物银行队列中进行外部验证。开发集包含1926例头颈癌病例和2043例对照,模型AUC为0.75(95% CI,0.74-0.77);外部验证集包含384 616名参与者(其中1177例头颈癌),AUC为0.62(95% CI,0.61-0.64)。作者认为该模型在初级牙科保健环境中可能有助于促进预防和确定牙科检查的召回间隔。
要点
- 开发集模型纳入社会人口学、吸烟和饮酒变量,AUC为0.75(95% CI,0.74-0.77),区分度中等。
- 外部验证中模型AUC为0.62(95% CI,0.61-0.64),作者评价为可接受的表现。
- 人口学特征和风险行为是头颈癌的强预测因子,该模型可能有助于初级牙科保健中的预防和确定复查间隔。
核心结论
- 作者利用ARCAGE和英国生物银行研究分别开发并外部验证了一个头颈癌风险预测模型。
- 该模型在开发人群中表现中等,在验证数据集中表现可接受。
- 人口学特征和风险行为是头颈癌的强预测因子,该模型可能是初级牙科保健环境中促进预防和确定牙科检查召回间隔的有用工具。
- 未来加入HPV血清学或遗传因素可能进一步增强个体风险预测。
研究设计与样本
- 模型开发数据集来自IARC-ARCAGE欧洲病例对照研究。
- 通过多变量逻辑回归分析开发了使用行为与人口学预测因子的头颈癌临床风险预测模型。
- 模型在英国生物银行队列中进行外部验证,并使用区分度和校准指标测试模型性能。
主要发现
- 开发集包含1926例头颈癌病例和2043例对照。
- 开发集模型纳入社会人口学、吸烟和饮酒变量,AUC为0.75(95% CI,0.74-0.77),校准斜率为0.75,校准检验提示校准良好。
- 外部验证集包含384 616名英国生物银行参与者,其中1177例头颈癌病例。
- 外部验证中模型AUC为0.62(95% CI,0.61-0.64)。
临床怎么用
- 作者认为该模型可能是初级牙科保健环境中有助于促进预防和确定牙科检查召回间隔的工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Head and neck cancer (HNC) incidence is on the rise, often diagnosed at late stage and associated with poor prognoses. Risk prediction tools have a potential role in prevention and early detection. METHODS: The IARC-ARCAGE European case-control study was used as the model development dataset. A clinical HNC risk prediction model using behavioral and demographic predictors was developed via multivariable logistic regression analyses. The model was then externally validated in the UK Biobank cohort. Model performance was tested using discrimination and calibration metrics. RESULTS: 1926 HNC cases and 2043 controls were used for the development of the model. The development dataset model including sociodemographic, smoking, and alcohol variables had moderate discrimination, with an area under curve (AUC) value of 0.75 (95% CI, 0.74-0.77); the calibration slope (0.75) and tests were suggestive of good calibration. 384 616 UK Biobank participants (with 1177 HNC cases) were available for external validation of the model. Upon external validation, the model had an AUC of 0.62 (95% CI, 0.61-0.64). CONCLUSION: We developed and externally validated a HNC risk prediction model using the ARCAGE and UK Biobank studies, respectively. This model had moderate performance in the development population and acceptable performance in the validation dataset. Demographics and risk behaviors are strong predictors of HNC, and this model may be a helpful tool in primary dental care settings to promote prevention and determine recall intervals for dental examination. Future addition of HPV serology or genetic factors could further enhance individual risk prediction.
引用
- Smith CDL, McMahon AD, Lyall DM, et al. Development and external validation of a head and neck cancer risk prediction model. Head Neck. 2024. PMID: 38850089. doi:10.1002/hed.27834
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。